Generics take the spotlight as House talks drug legislation

Modern Healthcare: House lawmakers and representatives for generic drug companies clashed Wednesday over how to handle exclusivity periods in a way that will bring more generics to market.

Witnesses before the House Energy and Commerce Committee's health panel warned lawmakers that a proposal to potentially override existing settlements between brand and generic drug manufacturers could disrupt business, and spur lawsuits that could ultimately go against Congress' goal of bringing more generics to market.

Read article